MedPath
HSA Approval

DIGOKERN TABLETS 0.25MG

SIN17078P

DIGOKERN TABLETS 0.25MG

DIGOKERN TABLETS 0.25MG

September 10, 2024

APOTHECA MARKETING PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPOTHECA MARKETING PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C01AA05

Manufacturer Information

APOTHECA MARKETING PTE LTD

KERN PHARMA, S.L.

Active Ingredients

Digoxin

0.25mg

Digoxin

Documents

Package Inserts

Digokern Tablets PI.pdf

Approved: September 10, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DIGOKERN TABLETS 0.25MG - HSA Approval | MedPath